tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jonathan Wolleben, 211 are a BUY (99.53%), 1 are a HOLD (0.47%).
Analyst Jonathan Wolleben, currently employed at JMP, carries an average stock price target met ratio of 35.37% that have a potential upside of 56.02% achieved within 220 days.
Jonathan Wolleben’s has documented 412 price targets and ratings displayed on 20 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MDGL, Madrigal Pharmaceuticals at 20-Aug-2025.
Analyst best performing recommendations are on RYTM (RHYTHM PHARMACEUTICALS).
The best stock recommendation documented was for RYTM (RHYTHM PHARMACEUTICALS) at 6/26/2025. The price target of $84 was fulfilled within 13 days with a profit of $22.55 (36.7%) receiving and performance score of 28.23.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$18
$14.22 (376.19%)
$20
1 months 12 days ago
(13-Aug-2025)
4/17 (23.53%)
$14.26 (381.28%)
214
Buy
$12
$8.22 (217.46%)
$12
1 months 12 days ago
(13-Aug-2025)
0/19 (0%)
$8.26 (220.86%)
Buy
$15
$11.22 (296.83%)
$25
2 months 15 days ago
(10-Jul-2025)
0/16 (0%)
$10.6 (240.91%)
Sell
$1
$-2.78 (-73.54%)
$13
2 months 15 days ago
(10-Jul-2025)
1/4 (25%)
$-3.4 (-77.27%)
34
Buy
$25
$21.22 (561.38%)
$25
1 years 3 months 4 days ago
(21-Jun-2024)
3/14 (21.43%)
$18.59 (290.02%)
42
Which stock is Jonathan Wolleben is most bullish on?
Which stock is Jonathan Wolleben is most reserved on?
What Year was the first public recommendation made by Jonathan Wolleben?
